Baqsimi
glucagon
- Strength
- 3 mg/1
- Form
- Powder
- Class
- Antihypoglycemic Agent; Gastrointestina…
Amphastar Pharmaceuticals, Inc.
Not stocked by us — reference only
glucagon injection, solution
Listed by Xeris Pharmaceuticals, Inc.
| Dosage form | Injection, Solution |
|---|---|
| Route | Subcutaneous |
| Drug class | Antihypoglycemic Agent; Gastrointestinal Motility Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 72065-140 |
| FDA application | NDA212097 |
| RxNorm concept | 2199299 |
| Package sizes listed | 1 |
| Marketed since | October 2021 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
glucagon
Amphastar Pharmaceuticals, Inc.
Not stocked by us — reference only
glucagon
Amphastar Pharmaceuticals, Inc.
Not stocked by us — reference only
glucagon
Sportpharm LLC
Not stocked by us — reference only
Fresenius Kabi USA, LLC
Not stocked by us — reference only
Glucagon
Professional Complementary Health Formulas
Not stocked by us — reference only
glucagon injection, solution
Xeris Pharmaceuticals, Inc.
Not stocked by us — reference only
glucagon injection, solution
Xeris Pharmaceuticals, Inc.
Not stocked by us — reference only
glucagon injection, solution
Xeris Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.